Drug Type Small molecule drug |
Synonyms ABM 4095, ABM4095 |
Target |
Mechanism MEK inhibitors(Dual specificity mitogen-activated protein kinase kinase inhibitors), MEK1 inhibitors(Dual specificity mitogen-activated protein kinase kinase 1 inhibitors), MEK2 inhibitors(Dual specificity mitogen-activated protein kinase kinase 2 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | US | 05 Nov 2024 | |
Colorectal Cancer | Preclinical | CN | 05 Nov 2024 | |
Pancreatic Cancer | Preclinical | CN | 07 Apr 2024 |